The rising interest in potent weight management has spurred considerable research into novel treatments. Lately , Retatrutide, a combined -action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated encouraging results in clinical trials, indicating potential for substantial weight loss . As a result , several individuals a